组织芯片，组织微阵列

FUR801b	子宫疾病谱组织芯片，附病理分级、TNM和临床分期，80例/80点，替代UT801a
点数	80	例数	80
行数	8	列数	10
点直径(mm)	1.5	厚度(µm)	5.0
组织阵列类型	石蜡包埋	种属	人类
QA/QC	H&E and IHC confirmed
Applications	Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes	1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 30 minutes at 60℃ before the experiment; 3.Please choose a gentle repair method to avoid tissue detachment.

Legend:	Ute -Uterus Abd -Abdominal cavity Ova -Ovary Pel -Pelvic cavity Lym -Lymph node Col -Colon
	Hyperplasia () Inflammation () Malignant (I) Malignant (IB) Malignant (IC) Malignant (II) Malignant (IIB) Malignant (IIIA) Malignant (IIIC) Metastasis () NAT () Normal (*)

TISSUE ARRAYS FUR801b

	1	2	3	4	5	6	7	8	9	10
A	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE
B	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE
C	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE
D	ABD	COL	LYM	PEL	OVA	ABD	UTE	UTE	UTE	UTE
E	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE
F	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE
G	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE
H	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE	UTE

Pos	No	Age	Sex	Organ_Anatomic_Site	Pathology_diagnosis	Grade	TNM	Stage	Type	isBackUp
A1	1	60	F	Uterus	Endometrioid adenocarcinoma	1	T1BN0M0	IB	Malignant	N
A2	2	73	F	Uterus	Endometrioid adenocarcinoma	*	T1CN0M0	IC	Malignant	N
A3	3	62	F	Uterus	Endometrioid adenocarcinoma	1	T1N0M0	I	Malignant	N
A4	4	49	F	Uterus	Endometrioid adenocarcinoma	1	T1BN0M0	IB	Malignant	N
A5	5	43	F	Uterus	Endometrioid adenocarcinoma	1	T1N0M0	I	Malignant	N
A6	6	51	F	Uterus	Endometrioid adenocarcinoma	1	T1BN0M0	IB	Malignant	N
A7	7	62	F	Uterus	Endometrioid adenocarcinoma	1	1BN0M0	IB	Malignant	N
A8	8	62	F	Uterus	Endometrioid adenocarcinoma	*	T1CN1M0	IIIC	Malignant	N
A9	9	61	F	Uterus	Endometrioid adenocarcinoma	1	T1CN0M0	IC	Malignant	N
A10	10	63	F	Uterus	Endometrioid adenocarcinoma	2	T1CN0M0	IC	Malignant	N
B1	11	61	F	Uterus	Endometrioid adenocarcinoma	1	T1BN0M0	IB	Malignant	N
B2	12	51	F	Uterus	Endometrioid adenocarcinoma	1	T1BN0M0	IB	Malignant	N
B3	13	44	F	Uterus	Endometrioid adenocarcinoma	1	T1BN0M0	IB	Malignant	N
B4	14	56	F	Uterus	Endometrioid adenocarcinoma	2	T2N0M0	II	Malignant	N
B5	15	60	F	Uterus	Endometrioid adenocarcinoma	2	T1BN0M0	IB	Malignant	N
B6	16	58	F	Uterus	Endometrioid adenocarcinoma	*	T1BN0M0	IB	Malignant	N
B7	17	70	F	Uterus	Endometrioid adenocarcinoma	1	T1BN0M0	IB	Malignant	N
B8	18	63	F	Uterus	Endometrioid adenocarcinoma	1	T3AN0M0	IIIA	Malignant	N
B9	19	58	F	Uterus	Endometrioid adenocarcinoma	1	T1BN0M0	IB	Malignant	N
B10	20	56	F	Uterus	Endometrioid adenocarcinoma	2	T1BN0M0	IB	Malignant	N
C1	21	52	F	Uterus	Endometrioid adenocarcinoma	2	T1BN0M0	IB	Malignant	N
C2	22	54	F	Uterus	Endometrioid adenocarcinoma	2	T1N0M0	I	Malignant	N
C3	23	54	F	Uterus	Endometrioid adenocarcinoma	2	T1CN0M0	IC	Malignant	N
C4	24	63	F	Uterus	Endometrioid adenocarcinoma	3	T1CN0M0	IC	Malignant	N
C5	25	44	F	Uterus	Endometrioid adenocarcinoma	3	T1BN0M0	IB	Malignant	N
C6	26	55	F	Uterus	Adenosquamous carcinoma	*	T1BN0M0	IB	Malignant	N
C7	27	54	F	Uterus	Adenosquamous carcinoma	*	T2BN0M0	IIB	Malignant	N
C8	28	56	F	Uterus	Adenosquamous carcinoma	*	T1BN0M0	IB	Malignant	N
C9	29	73	F	Uterus	Adenosquamous carcinoma	*	T1BN0M0	IB	Malignant	N
C10	30	60	F	Uterus	Squamous cell carcinoma	*	T2N0M0	II	Malignant	N
D1	31	39	F	Abdominal cavity	Metastatic endometrioid adenocarcinoma	*	*	*	Metastasis	N
D2	32	76	F	Colon	Metastatic endometrioid adenocarcinoma	*	*	*	Metastasis	N
D3	33	45	F	Lymph node	Metastatic endometrioid adenocarcinoma of pelvic cavity	*	*	*	Metastasis	N
D4	34	69	F	Pelvic cavity	Metastatic endometrioid adenocarcinoma	*	*	*	Metastasis	N
D5	35	51	F	Ovary	Metastatic endometrioid adenocarcinoma	*	*	*	Metastasis	N
D6	36	40	F	Abdominal cavity	Metastatic endometrial adenosquamous carcinoma	*	*	*	Metastasis	N
D7	37	37	F	Uterus	Endometrial polyp	*	*	*	Hyperplasia	N
D8	38	57	F	Uterus	Endometrial polyp	*	*	*	Hyperplasia	N
D9	39	69	F	Uterus	Endometrial polyp	*	*	*	Hyperplasia	N
D10	40	47	F	Uterus	Endometrial simple hyperplasia	*	*	*	Hyperplasia	N
E1	41	83	F	Uterus	Severe atypical hyperplasia of endometrium	*	*	*	Hyperplasia	N
E2	42	52	F	Uterus	Endometrial simple hyperplasia	*	*	*	Hyperplasia	N
E3	43	65	F	Uterus	Endometrial simple hyperplasia	*	*	*	Hyperplasia	N
E4	44	40	F	Uterus	Endometrial simple hyperplasia	*	*	*	Hyperplasia	N
E5	45	43	F	Uterus	Endometrial simple hyperplasia	*	*	*	Hyperplasia	N
E6	46	37	F	Uterus	Endometrial simple hyperplasia	*	*	*	Hyperplasia	N
E7	47	49	F	Uterus	Endometrial simple hyperplasia	*	*	*	Hyperplasia	N
E8	48	70	F	Uterus	Moderate atypical hyperplasia of endometrium	*	*	*	Hyperplasia	N
E9	49	51	F	Uterus	Endometrial simple hyperplasia	*	*	*	Hyperplasia	N
E10	50	62	F	Uterus	Endometrial simple hyperplasia	*	*	*	Hyperplasia	N
F1	51	52	F	Uterus	Mild-moderate atypical hyperplasia of endometrium	*	*	*	Hyperplasia	N
F2	52	69	F	Uterus	Endometrial simple hyperplasia	*	*	*	Hyperplasia	N
F3	53	50	F	Uterus	Endometrial simple hyperplasia	*	*	*	Hyperplasia	N
F4	54	64	F	Uterus	Endometrial simple hyperplasia	*	*	*	Hyperplasia	N
F5	55	48	F	Uterus	Endometrial simple hyperplasia	*	*	*	Hyperplasia	N
F6	56	50	F	Uterus	Endometrial adenomatous hyperplasia	*	*	*	Hyperplasia	N
F7	57	69	F	Uterus	Mild-moderate atypical hyperplasia of endometrium	*	*	*	Hyperplasia	N
F8	58	44	F	Uterus	Moderate atypical hyperplasia of endometrium	*	*	*	Hyperplasia	N
F9	59	48	F	Uterus	Mild-moderate atypical hyperplasia of endometrium	*	*	*	Hyperplasia	N
F10	60	48	F	Uterus	Chronic endometritis	*	*	*	Inflammation	N
G1	61	60	F	Uterus	Chronic endometritis	*	*	*	Inflammation	N
G2	62	63	F	Uterus	Chronic endometritis	*	*	*	Inflammation	N
G3	63	65	F	Uterus	Chronic endometritis	*	*	*	Inflammation	N
G4	64	51	F	Uterus	Chronic endometritis	*	*	*	Inflammation	N
G5	65	41	F	Uterus	Adjacent normal endometrium tissue (secretory)	*	*	*	NAT	N
G6	66	41	F	Uterus	Adjacent normal endometrium tissue (secretory)	*	*	*	NAT	N
G7	67	37	F	Uterus	Adjacent normal endometrium tissue (proliferative-phase)	*	*	*	NAT	N
G8	68	40	F	Uterus	Adjacent normal endometrium tissue (proliferative-phase)	*	*	*	NAT	N
G9	69	53	F	Uterus	Adjacent normal endometrium tissue (proliferative-phase)	*	*	*	NAT	N
G10	70	61	F	Uterus	Adjacent normal endometrium tissue (proliferative-phase)	*	*	*	NAT	N
H1	71	41	F	Uterus	Adjacent normal endometrium tissue (proliferative-phase)	*	*	*	NAT	N
H2	72	43	F	Uterus	Adjacent normal endometrium tissue (proliferative-phase)	*	*	*	NAT	N
H3	73	44	F	Uterus	Adjacent normal endometrium tissue (secretory)	*	*	*	NAT	N
H4	74	34	F	Uterus	Adjacent normal endometrium tissue (proliferative-phase)	*	*	*	NAT	N
H5	75	63	F	Uterus	Adjacent normal endometrium tissue	*	*	*	NAT	N
H6	76	42	F	Uterus	Adjacent normal endometrium tissue (proliferative-phase)	*	*	*	NAT	N
H7	77	45	F	Uterus	Adjacent endometritis tissue	*	*	*	NAT	N
H8	78	40	F	Uterus	Normal endometrium tissue (proliferative-phase)	*	*	*	Normal	N
H9	79	21	F	Uterus	Normal endometrium tissue (proliferative-phase)	*	*	*	Normal	N
H10	80	21	F	Uterus	Normal endometrium tissue (secretory)	*	*	*	Normal	N
Tissue Marker